SUGAMMADEX BAXTER 100mg / ml injectible solution medication leaflet

V03AB35 sugamadex • Various | All other therapeutic products | Antidotes

Sugammadex is a reversal agent used to counteract the effects of neuromuscular blockers such as rocuronium and vecuronium after surgical procedures. It works by directly binding to the neuromuscular blocking agents, facilitating the recovery of muscle function.

The medication is administered intravenously, as directed by a doctor, usually at the end of surgery. It is important for administration to be performed under medical supervision.

Patients should be aware of potential side effects, such as nausea, hypotension, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, hypotension, and headache. In rare cases, severe reactions such as anaphylactic reactions may occur. Patients should be informed of these risks before administration.

General data about SUGAMMADEX BAXTER 100mg / ml

Substance: sugamadex

Date of last drug list: 01-12-2023

Commercial code: W69837002

Concentration: 100mg / ml

Pharmaceutical form: injectible solution

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: SOLUPHARM PHARMAZEUTISCHE ERZEUGNISSE GMBH - GERMANIA

Holder: BAXTER HOLDING BV - TARILE DE JOS

Number: 15159/2023/02

Shelf life: 4 years-after packing for marketing

Pharmaceutical forms available for sugamadex

Concentrations available for sugamadex

100mg/ml, 10mg/ml, 50mg/ml